312 related articles for article (PubMed ID: 19366247)
21. A selective estrogen receptor modulator designed for the treatment of uterine leiomyoma with unique tissue specificity for uterus and ovaries in rats.
Hummel CW; Geiser AG; Bryant HU; Cohen IR; Dally RD; Fong KC; Frank SA; Hinklin R; Jones SA; Lewis G; McCann DJ; Rudmann DG; Shepherd TA; Tian H; Wallace OB; Wang M; Wang Y; Dodge JA
J Med Chem; 2005 Nov; 48(22):6772-5. PubMed ID: 16250633
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic agents for disorders of bone and calcium metabolism: Bazedoxifene].
Chaki O
Clin Calcium; 2007 Jan; 17(1):30-5. PubMed ID: 17211091
[TBL] [Abstract][Full Text] [Related]
23. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
24. Estrogen to antiestrogen with a single methylene group resulting in an unusual steroidal selective estrogen receptor modulator.
Zhang JX; Labaree DC; Mor G; Hochberg RB
J Clin Endocrinol Metab; 2004 Jul; 89(7):3527-35. PubMed ID: 15240642
[TBL] [Abstract][Full Text] [Related]
25. The effects of the selective estrogen receptor modulators, methyl-piperidino-pyrazole (MPP), and raloxifene in normal and cancerous endometrial cell lines and in the murine uterus.
Davis AM; Ellersieck MR; Grimm KM; Rosenfeld CS
Mol Reprod Dev; 2006 Aug; 73(8):1034-44. PubMed ID: 16688783
[TBL] [Abstract][Full Text] [Related]
26. Effect of halogenated substituents on the metabolism and estrogenic effects of the equine estrogen, equilenin.
Liu X; Zhang F; Liu H; Burdette JE; Li Y; Overk CR; Pisha E; Yao J; van Breemen RB; Swanson SM; Bolton JL
Chem Res Toxicol; 2003 Jun; 16(6):741-9. PubMed ID: 12807357
[TBL] [Abstract][Full Text] [Related]
27. Pharmacology and clinical applications of selective estrogen receptor modulators.
Nath A; Sitruk-Ware R
Climacteric; 2009 Jun; 12(3):188-205. PubMed ID: 19387883
[TBL] [Abstract][Full Text] [Related]
28. Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy.
Gennari L
Expert Opin Pharmacother; 2009 Sep; 10(13):2209-20. PubMed ID: 19640205
[TBL] [Abstract][Full Text] [Related]
29. Genistein derivatives as selective estrogen receptor modulators: sonochemical synthesis and in vivo anti-osteoporotic action.
Wang SF; Jiang Q; Ye YH; Li Y; Tan RX
Bioorg Med Chem; 2005 Aug; 13(16):4880-90. PubMed ID: 15950478
[TBL] [Abstract][Full Text] [Related]
30. Raloxifene blocks estradiol induction of the serotonin transporter and 5-hydroxytryptamine2A receptor in female rat brain.
Sumner BE; Grant KE; Rosie R; Hegele-Hartung Ch; Fritzemeier KH; Fink G
Neurosci Lett; 2007 Apr; 417(1):95-9. PubMed ID: 17398000
[TBL] [Abstract][Full Text] [Related]
31. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor ligands. Part 6: Synthesis and binding affinity of dihydrobenzodithiins.
Tan Q; Birzin ET; Chan W; Yang YT; Pai LY; Hayes EC; DaSilva CA; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
Bioorg Med Chem Lett; 2004 Jul; 14(14):3753-5. PubMed ID: 15203156
[TBL] [Abstract][Full Text] [Related]
33. Molecular simulation of interaction between estrogen receptor and selective estrogen receptor modulators.
Guo ZR; Yi X; Xu ZB
Acta Pharmacol Sin; 2002 Mar; 23(3):208-12. PubMed ID: 11918843
[TBL] [Abstract][Full Text] [Related]
34. [Next generation selective estrogen receptor modulators].
Chaki O
Clin Calcium; 2006 Jan; 16(1):145-52. PubMed ID: 16397365
[TBL] [Abstract][Full Text] [Related]
35. Rapid synthesis of 4-benzylidene and 4-[bis-(4-methoxyphenyl)-methylene-2-substituted phenyl-benzopyrans as potential selective estrogen receptor modulators (SERMs) using McMurry coupling reaction.
Gupta A; Dwivedy A; Keshri G; Sharma R; Balapure AK; Singh MM; Ray S
Bioorg Med Chem Lett; 2006 Dec; 16(23):6006-12. PubMed ID: 16979337
[TBL] [Abstract][Full Text] [Related]
36. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
[TBL] [Abstract][Full Text] [Related]
37. Discovery and structure-activity analysis of selective estrogen receptor modulators via similarity-based virtual screening.
Shen J; Jiang J; Kuang G; Tan C; Liu G; Huang J; Tang Y
Eur J Med Chem; 2012 Aug; 54():188-96. PubMed ID: 22647217
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis and bioevaluation of novel candidate selective estrogen receptor modulators.
Yadav Y; Maclean ED; Bhattacharyya A; Parmar VS; Balzarini J; Barden CJ; Too CK; Jha A
Eur J Med Chem; 2011 Sep; 46(9):3858-66. PubMed ID: 21680064
[TBL] [Abstract][Full Text] [Related]
39. Benzothiophenes containing a piperazine side chain as selective ligands for the estrogen receptor alpha and their bioactivities in vivo.
Yang C; Xu G; Li J; Wu X; Liu B; Yan X; Wang M; Xie Y
Bioorg Med Chem Lett; 2005 Mar; 15(5):1505-7. PubMed ID: 15713417
[TBL] [Abstract][Full Text] [Related]
40. Effects of 3-phenyl-4-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]- 2H-1-benzopyran-7-ol (CHF 4056), a novel nonsteroidal estrogen agonist/antagonist, on reproductive and nonreproductive tissue.
Galbiati E; Caruso PL; Amari G; Armani E; Ghirardi S; Delcanale M; Civelli M
J Pharmacol Exp Ther; 2002 Mar; 300(3):802-9. PubMed ID: 11861784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
